glutathione and glutamate cysteine ligase cyn Covalent Targeting of to Inhibit Synthesis Glutamyl cycle, 1 Glutamate cysteine

PMID 2868390

Gane 19 and Maria Buti 20 , (1)Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South), (2)Medical Data Analytics Centre (MDAC), the Chinese University of Hong Kong, (3)Department of Internal Medicine, Yonsei University College of Medicine, (4)Department of Medicine, School of Clinical Medicine, the University of Hong Kong, (5)Institute of Liver Studies, King's College Hospital, (6)Toronto Centre for Liver Disease, University Health Network, (7)Erasmus Medical Center, (8)NYU Langone Health, New York University Grossman School of Medicine, (9)Kaohsiung Medical University Hospital, Kaohsiung Medical University, (10)Department of Medicine, University of Toronto, Toronto, ON, Canada, (11)All India Institute of Medical Sciences, India, (12)Azienda Ospedaliero-Universitaria Pisana, (13)Alice Ho Miu Ling Nethersole Hospital, (14)National Cheng Kung University Hospital, (15)National University Health System, Singapore, Singapore, (16)Gilead Sciences, Inc., (17)National Taiwan University College of Medicine, (18)Hpital Beaujon, Aphp, University of Paris, (19)University of Auckland, (20)Hospital Universitario Vall D'hebron and Ciberehd Del Instituto Carlos III Background: Antiviral therapy reduces HCC risk in patients with CHB, particularly with TDF or entecavir

Truly the best place ever

doi: 10.1016/j.bbamcr.2006.08.039 52 SalsburyFRJr.KnutsonSTPooleLBFetrowJS